Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 168

The DOI matches its Crossref record.

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP‐1 monocyte/macrophages

Open access
Reiss, Allison B., Carsons, Steven E., Anwar, Kamran, Rao, Soumya, Edelman, Sari D., Zhang, Hongwei, Fernandez, Patricia, Cronstein, Bruce N., Chan, Edwin S. L. · 2008 · Arthritis & Rheumatism

Abstract

Objective: To determine whether methotrexate (MTX) can overcome the atherogenic effects of cyclooxygenase 2 (COX‐2) inhibitors and interferon‐γ (IFNγ), both of which suppress cholesterol efflux protein and promote foam cell transformation in human THP‐1 monocyte/macrophages. Methods: Message and protein levels of the reverse cholesterol transport proteins cholesterol 27‐hydroxylase and ATP‐binding cassette transporter A1 (ABCA1) in THP‐1 cells were evaluated by real‐time polymerase chain reaction and immunoblot, respectively. Expression was evaluated in cells incubated in the presence or absence of the COX‐2 inhibitor NS398 or IFNγ, with and without MTX. Foam cell transformation of lipid‐laden THP‐1 macrophages was detected with oil red O staining and light microscopy. Results: MTX increased 27‐hydroxylase message and completely blocked NS398‐induced down‐regulation of 27‐hydroxylase (mean ± SEM 112.8 ± 13.1% for NS398 plus MTX versus 71.1 ± 4.3% for NS398 alone; P < 0.01). MTX also negated COX‐2 inhibitor–mediated down‐regulation of ABCA1. The ability of MTX to reverse inhibitory effects on 27‐hydroxylase and ABCA1 was blocked by the adenosine A 2A receptor–specific antagonist ZM241385. MTX also prevented NS398 and IFNγ from increasing transformation of lipid‐laden THP‐1 macrophages into foam cells. Conclusion: This study provides evidence supporting the notion of an atheroprotective effect of MTX. Through adenosine A 2A receptor activation, MTX promotes reverse cholesterol transport and limits foam cell formation in THP‐1 macrophages. This is the first reported evidence that any commonly used medication can increase expression of antiatherogenic reverse cholesterol transport proteins and can counteract the effects of COX‐2 inhibition. Our results suggest that one mechanism by which MTX protects against cardiovascular disease in rheumatoid arthritis patients is through facilitation of cholesterol outflow from cells of the artery wall.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.24040

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Reiss, A. B., Carsons, S. E., Anwar, K., Rao, S., Edelman, S. D., Zhang, H., Fernandez, P., Cronstein, B. N., & Chan, E. S. L.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2008-11-26
Volume
58
Issue
12
Pages
3675-3683
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2028420196
Cited by
168
References
0
FWCI
8.73
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.